| Product Code: ETC6016118 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan Pregabalin Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan Pregabalin Market - Industry Life Cycle |
3.4 Afghanistan Pregabalin Market - Porter's Five Forces |
3.5 Afghanistan Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Afghanistan Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Afghanistan Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Afghanistan Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Afghanistan |
4.2.2 Growing awareness about the benefits of pregabalin in managing neuropathic pain |
4.2.3 Rise in healthcare expenditure and infrastructure development in the country |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Afghanistan |
4.3.2 Concerns regarding the misuse and abuse of pregabalin |
4.3.3 Challenges related to regulatory approvals and pricing of pregabalin in the Afghan market |
5 Afghanistan Pregabalin Market Trends |
6 Afghanistan Pregabalin Market, By Types |
6.1 Afghanistan Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Afghanistan Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Afghanistan Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 Afghanistan Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 Afghanistan Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Afghanistan Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 Afghanistan Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 Afghanistan Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Afghanistan Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Afghanistan Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Afghanistan Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 Afghanistan Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 Afghanistan Pregabalin Market Import-Export Trade Statistics |
7.1 Afghanistan Pregabalin Market Export to Major Countries |
7.2 Afghanistan Pregabalin Market Imports from Major Countries |
8 Afghanistan Pregabalin Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pregabalin treatment |
8.2 Percentage increase in prescriptions of pregabalin by healthcare providers |
8.3 Patient-reported outcomes on the effectiveness of pregabalin in managing neurological disorders |
9 Afghanistan Pregabalin Market - Opportunity Assessment |
9.1 Afghanistan Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Afghanistan Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Afghanistan Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Afghanistan Pregabalin Market - Competitive Landscape |
10.1 Afghanistan Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here